Hematopoietic Sphingosine 1-Phosphate Lyase Deficiency Decreases Atherosclerotic Lesion Development in LDL-Receptor Deficient Mice

• Martine Bot,

  Affiliation Division of Biopharmaceutics, Leiden Academic Centre for Drug Research, Leiden University, Leiden, The Netherlands

  ⨯
• Paul P. Van Veldhoven,

  Affiliation LIPIT, Department of Molecular Cell Biology, K.U. Leuven, Leuven, Belgium

  ⨯
• Saskia C. A. de Jager,

  Affiliation Division of Biopharmaceutics, Leiden Academic Centre for Drug Research, Leiden University, Leiden, The Netherlands

  ⨯
• Jason Johnson,

  Affiliation Bristol Heart Institute, Bristol Royal Infirmary, Bristol, England

  ⨯
• Niels Nijstad,

  Affiliation Department of Pediatrics, Center for Liver, Digestive, and Metabolic Diseases, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands

  ⨯
• Peter J. Van Santbrink,

  Affiliation Division of Biopharmaceutics, Leiden Academic Centre for Drug Research, Leiden University, Leiden, The Netherlands

  ⨯
• Marijke M. Westra,

  Affiliation Division of Biopharmaceutics, Leiden Academic Centre for Drug Research, Leiden University, Leiden, The Netherlands

  ⨯
• Gerd Van Der Hoeven,

  Affiliation LIPIT, Department of Molecular Cell Biology, K.U. Leuven, Leuven, Belgium

  ⨯
• Marion J. Gijbels,

  Affiliation Experimental Vascular Pathology Group, Department of Pathology, Maastricht University Medical Center, Maastricht, The Netherlands

  ⨯
• Carsten Müller-Tidow,

  Affiliation Department of Medicine, Hematology and Oncology, University Hospital Münster, Münster, Germany

  ⨯
• Georg Varga,

  Affiliation Institute of Experimental Dermatology, University of Münster, Münster, Germany

  ⨯
• Uwe J. F. Tietge,

  Affiliation Department of Pediatrics, Center for Liver, Digestive, and Metabolic Diseases, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands

  ⨯
• Johan Kuiper,

  Affiliation Division of Biopharmaceutics, Leiden Academic Centre for Drug Research, Leiden University, Leiden, The Netherlands

  ⨯
• Theo J. C. Van Berkel,

  Affiliation Division of Biopharmaceutics, Leiden Academic Centre for Drug Research, Leiden University, Leiden, The Netherlands

  ⨯
• Jerzy-Roch Nofer,

  Affiliations Center for Laboratory Medicine, University Hospital Münster, Münster, Germany, Department of Internal Medicine, Endocrinology, and Geriatrics, University of Modena and Reggio Emilia, Modena, Italy

  ⨯
• Ilze Bot ,

  Contributed equally to this work with: Ilze Bot, Erik A. L. Biessen

  * E-mail: i.bot@lacdr.leidenuniv.nl

  Affiliation Division of Biopharmaceutics, Leiden Academic Centre for Drug Research, Leiden University, Leiden, The Netherlands

  ⨯
•  [ ... ],
• Erik A. L. Biessen

  Contributed equally to this work with: Ilze Bot, Erik A. L. Biessen

  Affiliations Division of Biopharmaceutics, Leiden Academic Centre for Drug Research, Leiden University, Leiden, The Netherlands, Experimental Vascular Pathology Group, Department of Pathology, Maastricht University Medical Center, Maastricht, The Netherlands

  ⨯
• [ view all ]
• [ view less ]